檢索結果 - Sorbye, Halfdan
- Showing 1 - 20 results of 32
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy f... 由 Winther, Stine Braendegaard, Österlund, Pia, Berglund, Åke, Glimelius, Bengt, Qvortrup, Camilla, Sorbye, Halfdan, Pfeiffer, Per
出版 2017Text -
6
-
7
Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases 由 Løes, Inger Marie, Immervoll, Heike, Sorbye, Halfdan, Angelsen, Jon‐Helge, Horn, Arild, Knappskog, Stian, Lønning, Per Eystein
出版 2016Text -
8
-
9
High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer 由 Siesing, Christina, Sorbye, Halfdan, Dragomir, Anca, Pfeiffer, Per, Qvortrup, Camilla, Pontén, Fredrik, Jirström, Karin, Glimelius, Bengt, Eberhard, Jakob
出版 2017Text -
10
CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup 由 Aasebø, Kristine, Dragomir, Anca, Sundström, Magnus, Mezheyeuski, Artur, Edqvist, Per-Henrik, Eide, Geir Egil, Ponten, Fredrik, Pfeiffer, Per, Glimelius, Bengt, Sorbye, Halfdan
出版 2020Text -
11
High BRAF Mutation Frequency and Marked Survival Differences in Subgroups According to KRAS/BRAF Mutation Status and Tumor Tissue Availability in a Prospective Population-Based Met... 由 Sorbye, Halfdan, Dragomir, Anca, Sundström, Magnus, Pfeiffer, Per, Thunberg, Ulf, Bergfors, Monica, Aasebø, Kristine, Eide, Geir Egil, Ponten, Fredrik, Qvortrup, Camilla, Glimelius, Bengt
出版 2015Text -
12
Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) – study protocol for a national multicentre rando... 由 Labori, Knut Jørgen, Lassen, Kristoffer, Hoem, Dag, Grønbech, Jon Erik, Søreide, Jon Arne, Mortensen, Kim, Smaaland, Rune, Sorbye, Halfdan, Verbeke, Caroline, Dueland, Svein
出版 2017Text -
13
Consequences of a high incidence of microsatellite instability and BRAF‐mutated tumors: A population‐based cohort of metastatic colorectal cancer patients 由 Aasebø, Kristine Ø., Dragomir, Anca, Sundström, Magnus, Mezheyeuski, Artur, Edqvist, Per‐Henrik, Eide, Geir Egil, Ponten, Fredrik, Pfeiffer, Per, Glimelius, Bengt, Sorbye, Halfdan
出版 2019Text -
14
Prognostic role of tumour-infiltrating lymphocytes and macrophages in relation to MSI, CDX2 and BRAF status: a population-based study of metastatic colorectal cancer patients 由 Aasebø, Kristine, Bruun, Jarle, Bergsland, Christian H., Nunes, Luís, Eide, Geir Egil, Pfeiffer, Per, Dahl, Olav, Glimelius, Bengt, Lothe, Ragnhild A., Sorbye, Halfdan
出版 2021Text -
15
Plasma YKL-40 in Patients with Metastatic Colorectal Cancer Treated with First Line Oxaliplatin-Based Regimen with or without Cetuximab: RESULTS from the NORDIC VII Study 由 Tarpgaard, Line S., Guren, Tormod K., Glimelius, Bengt, Christensen, Ib J., Pfeiffer, Per, Kure, Elin H., Sorbye, Halfdan, Ikdahl, Tone, Yilmaz, Mette, Johansen, Julia S., Tveit, Kjell Magne
出版 2014Text -
16
Let-7 miRNA-binding site polymorphism in the KRAS 3(′)UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorecta... 由 Kjersem, Janne B, Ikdahl, Tone, Guren, Tormod, Skovlund, Eva, Sorbye, Halfdan, Hamfjord, Julian, Pfeiffer, Per, Glimelius, Bengt, Kersten, Christian, Solvang, Hiroko, Tveit, Kjell M, Kure, Elin H
出版 2012Text -
17
Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer 由 Thomsen, Maria, Kersten, Christian, Sorbye, Halfdan, Skovlund, Eva, Glimelius, Bengt, Pfeiffer, Per, Johansen, Julia S., Kure, Elin H., Ikdahl, Tone, Tveit, Kjell Magne, Christoffersen, Thoralf, Guren, Tormod Kyrre
出版 2016Text -
18
Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome 由 Thomsen, Maria, Skovlund, Eva, Sorbye, Halfdan, Bolstad, Nils, Nustad, Kjell Johannes, Glimelius, Bengt, Pfeiffer, Per, Kure, Elin H., Johansen, Julia S., Tveit, Kjell Magne, Christoffersen, Thoralf, Guren, Tormod Kyrre
出版 2018Text -
19
Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3) 由 Ali, Abir Salwa, Grönberg, Malin, Langer, Seppo W., Ladekarl, Morten, Hjortland, Geir Olav, Vestermark, Lene Weber, Österlund, Pia, Welin, Staffan, Grønbæk, Henning, Knigge, Ulrich, Sorbye, Halfdan, Janson, Eva Tiensuu
出版 2018Text -
20
Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study 由 Guren, Tormod Kyrre, Thomsen, Maria, Kure, Elin H, Sorbye, Halfdan, Glimelius, Bengt, Pfeiffer, Per, Österlund, Pia, Sigurdsson, Fridbjörn, Lothe, Inger Marie Bowitz, Dalsgaard, Astrid Marie, Skovlund, Eva, Christoffersen, Thoralf, Tveit, Kjell Magne
出版 2017Text